27
Participants
Start Date
August 13, 2024
Primary Completion Date
October 14, 2026
Study Completion Date
January 14, 2028
Carboplatin/Paclitaxel
Induction: three cycles of intravenous carboplatin AUC5 (max 750 mg) and paclitaxel 175 mg/m2, during cycle 1, 2 and 3 (day 1, 22, 43)
Pembrolizumab
"Induction: two cycles of intravenous pembrolizumab 400 mg during cycle 1 and 3 (day 1 and 43)~Adjuvant: up to seven cycles of fixed-dose intravenous pembrolizumab 400 mg, on day 1 every 6 weeks within 3-9 weeks after surgery"
Partial or total penectomy with inguinal and/or pelvic lymph node dissection
Resection of part or all of the penis with complete removal of suspect lymphnodes in the inguinal and/or pelvic area
NOT_YET_RECRUITING
UZ Leuven, Leuven
RECRUITING
NKI-AVL, Amsterdam
Merck Sharp & Dohme LLC
INDUSTRY
The Netherlands Cancer Institute
OTHER